Cardio Diagnostics Income Tax Expense Over Time
| CDIOW Stock | USD 0.04 0 9.24% |
With this module, investors can use any or all of fundamental ratio historical patterns as a complementary method for asset selection as well as a tool for deciding entry and exit points. Many technical investors use fundamentals to limit their universe of possible portfolio assets.
Check out Cardio Diagnostics Performance and Cardio Diagnostics Correlation. Cardio |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cardio Diagnostics. If investors know Cardio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cardio Diagnostics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Revenue Per Share 0.002 | Quarterly Revenue Growth 3.562 | Return On Assets (0.98) | Return On Equity (2.93) |
The market value of Cardio Diagnostics is measured differently than its book value, which is the value of Cardio that is recorded on the company's balance sheet. Investors also form their own opinion of Cardio Diagnostics' value that differs from its market value or its book value, called intrinsic value, which is Cardio Diagnostics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cardio Diagnostics' market value can be influenced by many factors that don't directly affect Cardio Diagnostics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Cardio Diagnostics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Cardio Diagnostics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cardio Diagnostics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Cross Equities Income Tax Expense Analysis
Compare Cardio Diagnostics and related stocks such as Eliem Therapeutics, Scpharmaceuticals, and Milestone Pharmaceuticals Income Tax Expense Over Time
Select Fundamental| 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| SCPH | (326 K) | (326 K) | (326 K) | (326 K) | (326 K) | (326 K) | 6.5 M | 381 K | (224 K) | 1.4 M | 2.2 M | 2.5 M | 681 K | 458.1 K | 435.2 K |
| MIST | 4 K | 4 K | 4 K | 4 K | 4 K | 4 K | 4 K | 4 K | 74 K | (56 K) | (17 K) | (220 K) | (1.3 M) | (312 K) | (327.6 K) |
| MCRB | 42 K | 42 K | 42 K | 42 K | 1.6 M | (804 K) | 2.2 M | (1.6 M) | 1.3 M | (6 M) | (2.7 M) | (4.1 M) | 3.7 M | 14.9 M | 15.7 M |
| LUMO | (253 K) | 41 K | (788 K) | 130 K | 14.8 M | 6.7 M | (5.4 M) | (559 K) | (7 M) | 12 K | (14 M) | (636 K) | (13 K) | (29 K) | (30.4 K) |
Cardio Diagnostics and related stocks such as Eliem Therapeutics, Scpharmaceuticals, and Milestone Pharmaceuticals Income Tax Expense description
My Equities
My Current Equities and Potential Positions
| Cardio Diagnostics Holdings | CDIOW |
| Classification | Pharmaceutical Products |
| Location | Illinois; U.S.A |
| Exchange | NASDAQ Exchange |
USD 0.039
Additional Tools for Cardio Stock Analysis
When running Cardio Diagnostics' price analysis, check to measure Cardio Diagnostics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cardio Diagnostics is operating at the current time. Most of Cardio Diagnostics' value examination focuses on studying past and present price action to predict the probability of Cardio Diagnostics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cardio Diagnostics' price. Additionally, you may evaluate how the addition of Cardio Diagnostics to your portfolios can decrease your overall portfolio volatility.